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Background: Robot-assisted partial nephrectomy (RAPN) has been widely used worldwide, to determine whether
RAPN is a safe and effective alternative to open partial nephrectomy (OPN) via the comparison of RANP and OPN.
Methods: A comprehensive literature search was performed within the databases including PubMed, Cochrane Library,
and Embase updated on 30 September 2015. Summary data with their corresponding 95 % confidence intervals (CIs)
were calculated using a random effects or fixed effects model. Heterogeneity and publication bias were also evaluated.
Results: A total of 16 comparative studies including 3024 cases were used for this meta-analysis. There are no significant
differences in the demographic characteristic between the two groups, but the age was lower and the tumor size was
smaller for the RAPN group. RAPN had a longer operative time and warm ischemia time but which showed less
estimated blood loss, hospital stay, and perioperative complications. No differences existed in the margin status, the
change of glomerular filtration rate, transfusion rate, and conversion rate between the two groups. There was no
significant publication bias.
Conclusions: RAPN offered a lower rate of perioperative complications, less estimated blood loss, and shorter length of
hospital stay than OPN, suggesting that RAPN can be an effective alternative to OPN. Well-designed prospective
randomized controlled trials will be helpful in validating our findings.
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Renal tumor has become a significant threat to the
public health, with a high incidence rate of 12.6/10,000
and 6.7/10,000 for men in the developed and less devel-
oped regions, respectively [1]. Partial nephrectomy and
radical nephrectomy are the two surgical options to deal
with renal tumor. Because partial nephrectomy may have
less renal function impairment, better overall survival,
and equivalent oncological survival compared to radical
nephrectomy, the European Association of Urology rec-
ommended partial nephrectomy, when feasible, as a gold
standard treatment for patients presenting with small
renal carcinoma [2].
There are three different ways to perform partial
nephrectomy, namely the open partial nephrectomy
(OPN), laparoscopic partial nephrectomy (LPN), and
robot-assisted partial nephrectomy (RAPN). Among
these available nephron-sparing surgery options, OPN is
the most extensively studied and has been demonstrated
with comparable oncological efficacy, less incidence of
chronic kidney disease within a 10-year follow-up, less
cardiovascular morbidity, and overall mortality com-
pared to radical nephrectomy [3, 4]. LPN has been
shown to offer better cosmetic results, less postoperative
pain, shorter length of hospital stay, and faster postoper-
ative recovery than OPN, but the steep learning curve
leads to its limited diffusion in the high-volume refer-
ence centers and application to the small and less com-
plex tumors [5]. Although a few studies have compared
the perioperative outcomes of OPN and RAPN, their
results are inconsistent. Han et al. [6] and Alemozaffar
et al. [7] found that RAPN caused longer operative time
than OPN, whereas other studies [8–10] showed the
opposite finding. Regarding the complication rate, the com-
parison between RAPN and OPN in two studies [11, 12]
also yielded with conflicting results.
Based on these observations, we believe there is a neces-
sity for a systematic review to compare the perioperative
outcomes of RAPN and OPN with the most updated data
and draw a more accurate conclusion.
Methods
Publication search
The systematic review followed the Cochrane review
guidelines. A comprehensive literature search using the
combinations of key words “open,” “robotic/robot-
assisted,” and “partial nephrectomy” was done within the
electronic databases PubMed, Cochrane Library, and
Embase updated on 30 September 2015. The publica-
tions in English rather than other languages were col-
lected. The computer search was supplemented with
manual searches within the reference lists of all retrieved
studies, review articles, and conference abstracts. Two
authors (Chen Tao and Hu Hailong) reviewed the titlesand abstracts of all items returned by the search engine
to assess their relevance to this meta-analysis independ-
ently. When the two authors could not make an
agreement on certain items, Xie Linguo served as a third
reviewer to look into the full text and make a decision
that whether the publication is qualified for this study.
Inclusion and exclusion criteria
All available randomized controlled trials (RCTs) and
retrospective comparative studies (cohort or case-
control studies) that compared RAPN with OPN were
included. Studies of comparison of RAPN, LPN, and
OPN were also included as long as the data for RAPN
and OPN could be extracted and had at least one of the
outcomes mentioned in the paper. Editorials, review
articles, and animal experimental studies were excluded.
When multiple reports described the same population,
the most recent or complete report was used.
Data extraction
Data associated with the included studies were
extracted and summarized by two authors (Chen Tao
and XieLinguo) independently. A senior author (Hu
Hailong) was responsible for resolving disagreements
pertaining to data extraction if there were any. The
extracted information contained the demographic data
(age, gender, body mass index, tumor size, and the location
of tumor), the information about the source of controls,
study design, and sample size of the study population, and
the perioperative outcomes including operating time (OT),
warm ischemia time (WIT), blood loss, length of hospital
stay (HS), positive surgical margins (PSM) rate, change of
glomerular filtration rate (eGFR), perioperative complica-
tions rate, transfusion rate, and conversion rate (RPN con-
verted to laparoscopic or open partial nephrectomy, RPN
or OPN converted to radical nephrectomy). The day of
follow-up, the number of tumor recurrence, metastasis,
and death were also extracted.
Statistical analysis and quality assessment
The random effects model was used when significant het-
erogeneity existed among the included studies as assessed
by the inconsistency index (I2 > 50 %) and the chi-square
test with significance heterogeneity (p < 0.10); otherwise,
the fixed effects model was used [13]. The level of evidence
of the included studies was rated according to the criteria
provided by the Centre for Evidence-Based Medicine in
Oxford, UK (CEBM home page, available online http://
www.cebm.net/index.aspx?o=1025, accessed on September
5, 2014). The modified Newcastle-Ottawa scale was used
to assess the quality of the retrospective study [14] (The
Newcastle-Ottawa Scale (NOS) for assessing the quality of
non-randomized studies in meta-analyses. http://www.oh-
ri.ca/programs/clinical_epidemiology/oxford.asp, accessed
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three factors: assessment of outcome, comparability of the
study groups, and patient selection. A score ranging from
0 to 9 (represented by 0 to 9 stars) was provided as the
result of the assessment for each study, except for RCTs
(Table 1). The studies which scored by 6 or more stars
were considered to be of high quality. All the meta-
analyses were performed using Review Manager 5.2
(Cochrane Collaboration, Oxford, UK). Weighted mean
difference (WMD) and odds ratio (OR) were used to com-
pare continuous and dichotomous variables, respectively.
All results were reported with 95 % CIs. All reported p
values were two sides, the value of p < 0.05 was considered
to indicate statistical significance, and publication bias was
assessed by Funnel plots. The Clavien-Dindo score system
was used to stratified postoperative complication for sub-
group analysis [15].
Results
Literature search and characteristics of the included
studies
The results for each step of the literature search are shown
in Fig. 1. Eventually, a total of 16 publications fulfilled the
predefined inclusion criteria, including 15 full-text articles
[6–12, 16–23] and 1 conference abstract [24]. Two of the
13 studies compared the outcomes of patient groups strati-
fied by RENAL score [12, 20]. Thus, in total, there were 18
independent study populations included in this meta-
analysis. Of the 16 studies, 4 studies conducted the com-
parison of perioperative outcomes of RAPN, LPN, and
OPN [6, 7, 18, 21], 12 studies documented their single
center’s experience with RAPN versus OPN [6–10, 12, 16,
18, 19, 21–23], 3 studies [11, 17, 20] involved the multicen-
ter collaboration, and 10 studies [6, 7, 11, 12, 17–20, 22, 23]
matched the two approach with renal tumor nephrometry
score (RENAL or PADUA). Among the included studies,
there was 2 prospective nonrandomized comparative
study (level of evidence: II) [8, 11], 3 studies retrospective
analysis but prospective data collecting (level of evidence:
III) [6, 12, 16], 9 retrospective studies compared contem-
porary of patients (level of evidence: III) [7, 10, 17–23], 1
retrospective study used a historical series as the control
(level of evidence: IV) [9], and 1 retrospective study but a
conference abstract (level of evidence: IV) [24].
Our literature search found no randomized and
blinded studies available for this meta-analysis. Seven
studies [8, 10, 12, 16, 18, 20, 23] declared the duration of
follow-up for both groups. Table 1 summarizes the char-
acteristics of the included studies.
Demographic characteristics of the study populations
This meta-analysis involved 3024 cases (1103 cases for
RAPN and 1921 cases for OPN) (Table 2). There are no
significant differences in the gender, patients of benign:malignant, and body mass index (BMI) of patients
between RAPN and OPN, but the age was lower
(WMD, −1.52 years; 95 % CI, −2.53 to −0.51; p = 0.003)
and the tumor size was smaller for RAPN group
(WMD, −0.46 cm; 95 % CI, −0.66 to −0.26; p < 0.01).
Comparison of perioperative outcomes of RAPN and OPN
Table 3 summarizes the perioperative outcomes of
RAPN and OPN.
The operative time was statistically shorter in the OPN
group (WMD, 27.79 min; 95 % CI, 4.51 to 51.07; p = 0.02)
(Fig. 2a), but the estimated blood loss (WMD, −105.57 ml;
95 % CI, −160.78 to −50.36; p = 0.0002) (Fig. 2b) was less in
the RAPN group, and a significantly shorter postoperative
hospital stay (WMD, −2.06 day; 95 % CI, −2.62 to −1.51; p
< 0.001) (Fig. 2c) was found in the RAPN group. Eight stud-
ies [8, 10, 17, 19–21, 23, 24] examined the perioperative
transfusion, and we found that there was no significant dif-
ference in transfusion rate between RAPN and OPN (OR,
0.86; 95 % CI, 0.56 to 1.32; p = 0.50) (Fig. 2d). Seven studies
[9–12, 18, 21, 24] made the comparison of intraoperative
conversion rate of RAPN and OPN; as a result, we found
no difference in conversion rate between RAPN and OPN
(OR, 0.91; 95 % CI, 0.38 to 2.14; p = 0.83) (Fig. 2e). Thir-
teen of the 16 included studies for this meta-analysis ex-
amined the margin status of surgical specimens [8–12,
16–21, 23, 24], no significant difference was observed
regarding the positive margin rate between RAPN and
OPN based on the data from the 11 studies involving
2220 cases (OR, 0.93; 95 % CI, 0.57 to 1.52; p = 0.78)
(Fig. 2f). The overall warm ischemia time of RAPN was
significantly longer than that of OPN (WMD, 2.18 min;
95 % CI, 0.49 to 3.87; p = 0.01) as supported by the pooled
data from 10 studies [6, 8, 9, 11, 12, 19, 20, 23, 24] (Fig. 2g).
There was no difference in the change of eGFR between
RAPN and OPN (WMD, −0.56 ml/min per 1.73 m2; 95 %
CI, −2.35 to 1.23; p = 0.54) (Fig. 2h).
Comparison of complications of RAPN and OPN
Table 4 summarizes the complications of the two groups.
The overall complication rate of RAPN was
significantly lower than that of OPN (OR, 0.64; 95 % CI,
0.51 to 0.79; p < 0.001) by the pooled data from 15 stud-
ies [6, 8, 10–12, 16–24] (Fig. 2i). Intraoperative compli-
cation rate was available for 8 studies [8–11, 17–20], and
no significant difference existed between the two groups
(OR, 0.86; 95 % CI, 0.42 to 1.76; p = 0.68) (Fig. 2j). Post-
operative complication rate was mentioned in 13 studies
[6, 8–11, 16–20, 22–24], and patients from the 11 stud-
ies [6, 9–11, 16–18, 20, 22–24] were further divided into
the minor (Clavien classification 1–2) complication
subgroup and major (Clavien classification 3–5) compli-
cation subgroup. The pooled data favored RAPN for
lower rates of overall postoperative complication (OR,
Table 1 Characteristics of the included studies
Study Level of evidence Design Matchinga Follow-up (month)f RAPN/OPN No. of centers Quality scoreg
Wu et al. [10] IIIb R 1,2,3,4,6,8 12 (6–24)/12 (6–24) Single ☆☆☆☆☆☆☆
Vittori et al. [11] II PN 1,2,3,4,7,8 Perioperative Multicenter ☆☆☆☆☆☆
Masson-Lecomte et al. [16] IIIb RP 1,2,3,4,6,8 19 (6–30)/32 (12–40) Single ☆☆☆☆☆☆☆
Ficarra et al. [17] IIIb R 1,2,5,6,7,8 Perioperative Multicenter ☆☆☆☆☆☆☆
Kim et al. [24] IV R 1,2,3,4,5,6 NA/NA NA ☆☆☆☆
Lucas et al. [18] IIIb R 1,2,3,6,7,8,9 9.4 ± 7.6/21.1 ± 18.8 Single ☆☆☆☆☆☆
Han et al. [6] IIIb RP 1,2, 4,5,6,7,8 Perioperative Single ☆☆☆☆☆☆☆
Oh et al. [19] IIIb R 1,2,3,4,5,6,7, 8,9 Perioperative Single ☆☆☆☆☆☆☆☆
Lee et al. [9] IV R 1,2,5,6,8 NA/NA Single ☆☆☆☆☆
Alemozaffar et al. [7] IIIb R 2,3,4,5,6,7 Perioperative Single ☆☆☆☆☆☆
Simhan et al. [12] IIIb RP 1,2,3,4,6,7 17.1 ± 9.2/23.9 ± 20.5b; 21.3 ± 13.3/19.8 ± 11.1c Single ☆☆☆☆☆☆
Zargar et al. [20] IIIb R 1,2,3,5,6,7 7.8 (18.7)/14 (14.5)d; 4 (18)/19.6 (29.7)e Multicenter ☆☆☆☆☆☆
Boylu et al. [8] II PN 1,2,3,5,6,8 33 ± 13/37 ± 20 Single ☆☆☆☆☆☆
Mano et al. [22] IIIb R 1,2,3,4,5,6,7 Perioperative Single ☆☆☆☆☆☆
Miyake et al. [23] IIIb R 1,2,3,4,5,6,7,8 1/1 Single ☆☆☆☆☆☆
Webb et al. [21] IIIb R 1,2,5,6,8 NA/NA Single ☆☆☆☆☆
R retrospective, RP retrospective analysis, prospective data collecting, PN prospective non-randomized design, NA not available
aMatching: 1 = age; 2 = gender; 3 = body mass index; 4 = American Society of Anesthesiologists score; 5 = tumor laterality; 6 = tumor size; 7 = nephrometry score (RENAL or PADUA); 8 = pre-op eGFR; 9 = single surgeon
bModerate nephrometry group (NS 7–9)
cHigh nephrometry group (NS 10–12)
dSimple tumors (RENAL score 4–8)
eComplex tumors (RENAL score 9–12)
fThe follow-up time was reported in the form of “median (inter-quartile range)” or “mean ± standard deviation” or not recorded













Fig. 1 Flow diagram of the comprehensive literature search
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complication (OR, 0.62; 95 % CI, 0.46 to 0.83; p = 0.001),
and major complication (OR, 0.57; 95 % CI, 0.36 to 0.91;
p = 0.02) compared to OPN.
Comparison of postoperative efficacy of RAPN and OPN
Eight studies [8–10, 12, 16, 18, 20, 21] compared the recur-
rence or metastasis rate of the RAPN with that of the OPN.
Among the 8 studies, there were 13 recurrences, 1 metasta-
sis, and 5 deaths in the OPN group, 756 patients were in-
cluded, while there were 0 recurrence, 1 metastasis, and 2
deaths in the RAPN group including 380 patients. The ratio
of tumor recurrence metastasis and death were 2.5 and
0.8 % in the OPN and RAPN, respectively. However, the
data were not pooled for meta-analysis due to the different
lengths of follow-up period between the studies.
Heterogeneity and publication bias analysis
In this meta-analysis, the Q-test and the I2 index were
used to evaluate the heterogeneity across studies. As
shown in Fig. 2, there was no heterogeneity among the
Dichotomous variable, on the contrary, there was statis-
tically significant heterogeneity among the continuous
variables. Figure 3 shows that the funnel plots of the
studies included in this meta-analysis reported
perioperative complication rates. Almost all studies lie
inside the 95 % CIs (overall complication with P = 0.30;
intraoperative complication with P = 0.63; minor compli-
cation with P = 0.58; major complication with P = 0.07),with an even distribution around the vertical, indicating
no obvious reporting bias.
Discussion
LPN and RAPN have been increasingly accepted as min-
imally invasive nephron-sparing surgical modalities over
the past two decades. Several studies [25, 26] have made
the comparison and concluded that the surgical and on-
cologic outcomes provided by LPN are comparable to
those by OPN. However, LPN requires proficient laparo-
scopic skills and the steep learning curve limits its wide
application in partial nephrectomy. With the rapid
advances in technology, RAPN has emerged as a new
option to deal with small renal tumors, but whether
PARN is safe and effective to deal with renal masses, we
should compare it to OPN that is the matching standard
of treatment and has the robustness of data regarding
surgical and oncological results [27]. To make a com-
parison between RAPN and OPN, Wu et al. [10] per-
formed a meta-analysis with the data extracted from 8
studies including 3418 patients (757 patients in the
robotic group and 2661 patients in the open group);
however, 2 of the 8 studies compared only the cost be-
tween RAPN and OPN [28, 29], and thus only 1118
patients (359 patients in the robotic group and 759
patients in the open group) accounted for the compari-
son in their study.
Here, we collected the data from 16 studies [6–8, 10–
12, 16–24] including 3024 cases (1103 cases for RAPN
Table 2 Demographic and perioperative results of RAPN vs OPEN
Study (OPN/RAPN) Patients Males Age mean ± SD (year) Benign: malignant Tumor size mean ± SD size (cm) BMI mean ± SD (kg/m2)
Wu et al. [10] 94/51 62/35 NA/NA NA:NA/NA:NA NA/NA NA/NA
Vittori et al. [11] 198/105 123/69 63.8 ± 12.4/62.3 ± 11.6 42:156/14:91 3.5 ± 1.8/2.8 ± 1.5 NA/NA
Masson-Lecomte et al. [16] 58/42 40/22 60.8 ± 11.2/61.7 ± 10.9 8:33/6:52 3.1 ± 1.2/2.8 ± 1.4 26.5 ± 5.6/26.9 ± 4.2
Ficarra et al. [17] 200/200 131/121 62.4 ± 11.8/62.4 ± 10.6 NA:NA/NA:NA NA/NA NA/NA/
Kim et al. [24] 83/67 56/48 56.2 ± 14.7/51.5 ± 11.9 NA:NA/NA:NA 2.6 ± 1.7/2.3 ± 1.1 24.8 ± 3.3/24.2 ± 3.0
Lucas et al. [18] 54/27 38/19 NA/NA 10:44/10:17 NA/NA NA/NA
Han et al. [6] 354/147 270/108 55.3 ± 12.4/52.5 ± 11.9 NA:NA/NA:NA 2.80 ± 1.35/2.58 ± 1.13 24.5 ± 3.0/25.56 ± 3.2
Oh et al. [19] 100/100 69/70 54.59 ± 13.40/54.27 ± 11.52 NA:NA/NA:NA 2.59 ± 1.35/2.52 ± 1.26 25.14 ± 2.73/25.48 ± 3.47
Lee et al. [9] 234/69 164/50 54.36 ± 12.77/53.48 ± 11.85 NA:NA/NA:NA 2.58 ± 1.40/2.37 ± 1.26 24.49 ± 2.80/25.50 ± 3.20
Alemozaffar et al. [7] 25/25 19/15 61.9 ± 10.1/55.9 ± 11.7 0:25/0:25 3.3 ± 1.4/2.5 ± 1.0 30.1 ± 5.9/27.5 ± 3.8
Simhan et al. 1 2012 [12] 136/81 89/43 58.7 ± 11.2/56.6 ± 13.1 2:136/3:81 4.1 ± 2.3/3.2 ± 1.8 30.0 ± 7.0/30.7 ± 6.7
Simhan et al. 2 2012 [12] 54/10 28/6 59.4 ± 10.8/56.1 ± 10.7 2:54/1:10 5.4 ± 3.8/3.7 ± 2.5 30.9 ± 6.8/30.7 ± 3.5
Zargar et al. 1 2014 [20] 33/30 NA/NA NA/NA NA:NA/NA:NA NA/NA NA/NA
Zargar et al. 2 2014 [20] 52/10 NA/NA NA/NA 7 NA:NA/NA:NA NA/NA NA/NA
Boylu et al. [8] 20/46 14/29 56 ± 13.5/54 ± 12 6:14/9:37 4.04 ± 2.08/3.56 ± 1.36 27.5 ± 3.3/28.7 ± 3.1
Mano et al. [22] 190/63 132/46 NA/NA NA:NA/NA:NA NA/NA 29 (25–31.5)/29.1 (26.6–31.5)a
Miyake et al. [23] 15/16 10/14 64.2 ± 12.2/63.3 ± 13.2 NA:NA/NA:NA 3.2 ± 0.9/3.0 ± 0.9 24.4 ± 5.1/24.9 ± 4.2

































Wu et al. [10] NA/NA NA/NA NA/NA 0 (0.0)/0
(0.0)
NA/NA NA/NA 4 (4.3)/3 (5.9) 1 (1.1)/0
(0.0)
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(3.7)
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Alemozaffar et al. [7] 238.3 ± 119.5/
231.8 ± 44.2
NA/NA 275.4 ± 170.0/
178.0 ± 205.7
NA/NA 4.60 ± 1.68/
2.48 ± 0.68
NA/NA NA/NA NA/NA




NA/NA 256.5 ± 291.3/
131.3 ± 127.8









NA/NA 330.6 ± 406.0/
225.0 ± 304





Zargar et al. 1 2014 [20] 185.42 ± 5 6.4/
174.9 ± 61.7
NA/NA NA/NA 3 (9.1)/2 (6.7) NA/NA NA/NA 5 (15.2)/6 (20.0) NA/NA




NA/NA 4 (7.7)/1 (10.0) NA/NA NA/NA 8 (15.4)/0 (0.0) NA/NA






0 (0.0)/1 (2.1) 5.4 ± 2/
4.11 ± 1.5













Table 3 Perioperative outcomes of RAPN versus OPN (Continued)




NA/NA 2.47 ± 1.31/
1.51 ± 0.76
NA/NA NA/NA NA/NA










0 (0)/0 (0) 0 (0)/0
(0)
Webb et al. [21] NA/NA 30.69 ± 10.65a/
28.01 ± 9.34
NA/NA 1 (4.8)/1 (7.1) 4 (3–6)b/
3 (2–4)b
NA/NA 0 (0)/0 (0) 2 (9.5)/0
(0)
The data of OT, WIT, MBL, HS, and eGFR change are expressed as mean ± standard deviation. The positive margin, transfusion, and conversion are shown with the number of cases and its percentage (the value in
brackets) in each study
















Fig. 2 Forest plots of the perioperative outcomes of RAPN versus OPN. a Operative time. b Estimated blood loss. c Length of hospital stay. d
Transfusion rate. e Rate of conversion to radical nephrectomy. f Positive margin rate. g Warm ischemia time. h Estimated GFR change. i Overall
complication rate. j Intra-operative complicate rate. k Postoperative complication rate
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Alemozaffar et al. [7] 25/25 NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA
Simhan et al. 1 2012 [12] 136/81 68 (50.0)/
29 (35.8)
NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA
Simhan et al. 2 2012 [12] 54/10 35 (64.8)/
8 (80.0)
NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA
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14 (7)/4 (6) 11 (6)/
0 (0)












Webb et al. [21] 21/14 1 (4.7)/
1 (7.14)
NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA
NA not available
aClavien 1 and 2 complications
bClavien 3–5 complications













Fig. 3 Funnel plots illustrating meta-analysis of perioperative complication rates. a Overall complication. b Intraoperative complication. c Minor
complication. d Major complication. SE standard error, OR odds ratio
Shen et al. World Journal of Surgical Oncology  (2016) 14:220 Page 11 of 13and 1921 cases for OPN) to compare the outcomes
between RAPN and OPN. We notice that the tumor size of
the RAPN group is smaller than that of the OPN group.
This could be caused by the selection bias that RAPN is
recommended to deal with small renal masses, but we can
see that all of the included studies matched the two groups
with tumor size except Vittori et al. [11, 22]. Nephrometry
score, which derives from the systematic analysis of ana-
tomical renal tumor characteristics, plays an important role
in PN outcomes reporting because it indicates the degree
of technical complexity and permits valid comparison
among different cohorts. In this meta-analysis, we observed
11 studies [6, 7, 11, 12, 17–23] matched the two approaches
with renal tumor nephrometry score (RENAL or PADUA).
We believe that it is comparable for the two groups. RAPN
has a lower age than OPN, but all of the studies included in
this meta-analysis matched the two groups with age except
Alemozaffar et al. [7]. Together with these, demographic
characteristics of the study populations have a little impact
on the outcome of the two groups, although the selection
bias is existed.
The operative time was significantly longer in the RAPN
group than in the OPN group, Masson-Lecomte et al. [16]found that the difference in operative time was insignificant
between RAPN and OPN when “skin-to-skin” time (ex-
cluding the setup and docking time) rather than the total
operating room occupation time. And we can find that the
operative time in RAPN group was shorter than Wu et al.’s
[10] meta-analysis, we believe that the operative time of
RAPN will be shorter than OPN in the future, because
RAPA enables a flexible, precise, and rapid operation. On
the contrary, RAPN has better outcomes in terms of EBL
when compared with the open group. In addition to this,
length of hospital stay was significantly shorter in the
RAPN group. Boylu et al. [8] found that the mean oper-
ation time was significantly longer and the EBL was less for
the RAPN group, but they found that the mean postopera-
tive decline of hematocrit was not statistically different
between the two groups, which suggests that RAPN pro-
vided rapid convalescence, decreased hospital stay, and less
blood loss when compared to the OPN group. We did not
see the difference in the margin status between the two
groups in our analysis either. Additionally, no significant
differences in the transfusion rate and surgical conversion
rate between RAPN and OPN were observed in this study,
which also suggested that RAPN is comparable to OPN.
Shen et al. World Journal of Surgical Oncology  (2016) 14:220 Page 12 of 13Our analysis showed that the overall WIT was higher
in the RAPN group. WIT < 30 min is recommended in
order to reduce renal ischemic injury [30], and a more
recently published multicenter study suggests that the
optimal WIT should be <20 min in order to preserve op-
timal renal functions [5]. Thompson et al. [31] suggest
that WIT < 25 min is a safety standard for partial neph-
rectomy. Ideal WIT is still under debate in the current
literature, but most of the authors agreed that WIT <
25 min is a safety standard for partial nephrectomy. All
of the included studies in this meta-analysis meet the
standard, except the Simhan et al. [12] and Kim et al.
[24]. Since the amount of renal parenchyma removed ra-
ther than WIT is the determinant for the final degree of
renal function preservation [32, 33], WIT is unlikely to
be the limiting factor for RAPN. Despite the significantly
longer WIT in the RAPN group, we found that the
change of eGFR is comparable between the two groups,
suggesting that RAPN and OPN apparently have the
same efficacy on postoperative renal function.
We found that there was no significant difference in in-
traoperative complication rate between the two groups,
which was inconsistent with the finding by Wu et al. [10].
We pooled the data from 7 studies associated with Clavien
grade 2 complication, which requires treatment with
drugs, and found that RAPN had lower chance of Clavien
grade 2 complication than OPN; this can also be seen in
Clavien grade 3 complication (p = 0.003). Only 1 study
compared the Clavien grade 5 complication (death) and
found that there was no difference between the two
groups (p = 0.421). Zhang et al. [34] compared the peri-
operative and oncologic outcomes of localized renal
tumors treated by RAPN with those treated by LPN and
found no difference between them. Vittori et al. [11] dem-
onstrated that open surgical approach is the only inde-
pendent risk factor associated with Clavien grade 3–4
complications. Here, we found that there was no differ-
ence between RAPN and OPN regarding Clavien grade
3–4 complications. In the subgroup analysis of postopera-
tive complications, minor complications and major
complications frequently occurred following OPN group.
A trend was observed toward a higher failure of cancer
control rate for OPN (2.5 versus 0.8 %), it is not appropri-
ate to estimate the weighted effect with the hazard ratio of
tumor recurrence and metastasis for the differences in the
length of follow-up duration between the studies.
We realize that there are limitations in this meta-
analysis. Firstly, all the included studies are retrospective,
non-randomized comparisons, except 2 prospectively
derived comparative studies. Secondly, no follow-ups of
long period have been achieved for RAPN, so the data
availability for tumor recurrence and metastasis were
quite limited. Thirdly, all continuous variables had a big
heterogeneity which may contribute to the differentsample sizes, multiple surgeons with different surgical
experiences, tumor complexity, and the lack of RENAL
standardization between groups. In addition, almost all
previous studies deal with small renal masses. This re-
minds us a caution of potential selection bias. As a
newly emerging surgical option for the treatment of
renal masses, RAPN should be compared to OPN that
has robust data regarding the surgical and oncological
outcomes and serves as the justification standard. Al-
though it will be helpful to perform prospective random-
ized studies comparing RAPN with OPN, such studies
in need of recruiting a homogeneous group of patients
with renal masses are difficult to carry out under the
context of real clinic.
Conclusions
This meta-analysis reveals that RAPN results in a signifi-
cantly lower rate of perioperative complications, less
estimated blood loss, and shorter hospital stay, but lon-
ger operative time and estimated warm ischemia time
than that of open approach. There are no differences in
the margin status, transfusion rate, and conversion rate
between RAPN and OPN. Thus, RAPN can be an effect-
ive alternative to OPN. Well-designed prospective ran-
domized controlled trials will be helpful in validating
our findings. With the accumulating knowledge about
RAPN, LPN, and OPN, the best decisions regarding the
surgical technique for organ-sparing renal tumor
resection may be made under the consideration of both
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